Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
Conditions: Recurrent Endometrial Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma Interventions: Drug: Abemaciclib; Drug: Anastrozole; Drug: Letrozole Sponsors: Jonsson Comprehensive Cancer Center; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arimidex | Cancer | Cancer & Oncology | Carcinoma | Endometrial Cancer | Ovarian Cancer | Ovaries | Research